Cytokinetics: No Effect of Omecamtiv Mecarbil On Exercise Capacity in Heart Failure

 No Effect of Omecamtiv Mecarbil On Exercise Capacity

in Patients with Heart Failure with Reduced Ejection Fraction in METEORIC-HF

Healthcare Resource Utilization and Cost Analysis from GALACTIC-HF Demonstrate Treatment with Omecamtiv Mecarbil Led to 19% Cost Reduction Per Patient in Key Subgroup

Additional Results from GALACTIC-HF Indicate Treatment with Omecamtiv Mecarbil
Associated with Similar Risk Reduction in Both Hospitalized Patients and Outpatients

https://www.marketscreener.com/quote/stock/CYTOKINETICS-INCORPORATE-13479846/news/Cytokinetics-Announces-Results-From-METEORIC-HF-and-Additional-Data-From-GALACTIC-HF-Presented-at-th-39953238/